Allena Pharmaceuticals Inc EV/EBIT
What is the EV/EBIT of Allena Pharmaceuticals Inc?
The EV/EBIT of Allena Pharmaceuticals Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Allena Pharmaceuticals Inc
Companies with ev/ebit similar to Allena Pharmaceuticals Inc
- Hi Crush Inc has EV/EBIT of N/A
- Cocrystal Pharma Inc has EV/EBIT of N/A
- Panorama Capital has EV/EBIT of N/A
- Nuverra Environmental Solutions Inc has EV/EBIT of N/A
- Touchpoint has EV/EBIT of N/A
- Equity Metals has EV/EBIT of N/A
- Allena Pharmaceuticals Inc has EV/EBIT of N/A
- Queen's Road Capital Investment has EV/EBIT of N/A
- Uxin Ltd has EV/EBIT of N/A
- Red Light Holland has EV/EBIT of N/A
- St. James Gold has EV/EBIT of N/A
- Eat Beyond Global has EV/EBIT of N/A
- Consolidated Firstfund Capital has EV/EBIT of N/A